Alexion Pharmaceuticals (ALXN +2%) is one of today's few gainers after a report says Soliris,...

|About: Alexion Pharmaceuticals, Inc. (ALXN)|By:, SA News Editor

Alexion Pharmaceuticals (ALXN +2%) is one of today's few gainers after a report says Soliris, the company's only drug, may be found to treat other rare diseases besides the life-threatening blood disorder PNH. The company expects the FDA to decide if Soliris can be marketed to treat a rare kidney disease as early as Q4.